Jaguar Health, Inc.
JAGX
$0.31
-$0.05-14.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.68M | 8.85M | -23.06M | -9.50M | -10.41M |
| Total Depreciation and Amortization | 542.00K | 520.00K | 543.00K | 557.00K | 556.00K |
| Total Amortization of Deferred Charges | 432.00K | -- | 153.00K | -- | -- |
| Total Other Non-Cash Items | 5.24M | 802.00K | 4.36M | 2.21M | 3.04M |
| Change in Net Operating Assets | 1.13M | -1.34M | 12.52M | 2.05M | 621.00K |
| Cash from Operations | -5.34M | 8.83M | -5.49M | -4.69M | -6.20M |
| Capital Expenditure | -- | -- | 13.00K | -54.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 13.00K | -54.00K | -- |
| Total Debt Issued | -- | -- | 10.00M | 0.00 | -3.00K |
| Total Debt Repaid | -298.00K | -6.44M | -170.00K | -199.00K | -145.00K |
| Issuance of Common Stock | -- | -- | -- | 4.20M | 2.83M |
| Repurchase of Common Stock | -- | -- | -56.00K | -- | -- |
| Issuance of Preferred Stock | 1.83M | -- | 0.00 | 2.38M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 334.00K | -180.00K | 16.00K | -114.00K | -30.00K |
| Cash from Financing | 1.86M | -6.62M | 9.79M | 6.26M | 2.66M |
| Foreign Exchange rate Adjustments | 2.00K | 17.00K | -10.00K | -196.00K | 57.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.47M | 2.23M | 4.31M | 1.32M | -3.48M |